Introduction
Neurostimulation involves the implantation of devices to stimulate the brain, spinal
cord, or peripheral or cranial nerves for the purpose of modulating the neural activity
of the targeted structures to achieve specific therapeutic effects. Surgical placement
of neurostimulation devices is associated with risks of neurologic injury, as well
as possible sequelae from the local or systemic effects of the intervention. The goal
of the Neurostimulation Appropriateness Consensus Committee (NACC) is to improve the
safety of neurostimulation.
Methods
The International Neuromodulation Society (INS) is dedicated to improving neurostimulation
efficacy and patient safety. Over the past two decades the INS has established a process
to use best evidence to improve care. This article updates work published by the NACC
in 2014. NACC authors were chosen based on nomination to the INS executive board and
were selected based on publications, academic acumen, international impact, and diversity.
In areas in which evidence was lacking, the NACC used expert opinion to reach consensus.
Results
The INS has developed recommendations that when properly utilized should improve patient
safety and reduce the risk of injury and associated complications with implantable
devices.
Conclusions
On behalf of INS, the NACC has published recommendations intended to reduce the risk
of neurological injuries and complications while implanting stimulators.
Keywords:
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe toAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- Incidence and avoidance of neurologic complications with paddle type spinal cord stimulation leads.Neuromodulation. 2011; 14 (discussion 422): 412-422
- Polyanalgesic Consensus Conference recommendations for intrathecal drug delivery: guidance for improving safety and mitigating risk.Neuromodulation. 2017; 20: 155-175
- Current methods of the US Preventive Services Task Force: a review of the process.Am J Prev Med. 2001; 20: 21-35
- Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee.Infect Control Hosp Epidemiol. 1999; 20: 250-278
- The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain.Neuromodulation. 2014; 17: 571-597
- The Neurostimulation Appropriateness Consensus Committee (NACC) recommendations on bleeding and coagulation management in neurostimulation devices.Neuromodulation. 2017; 20: 51-62
- The Neurostimulation Appropriateness Consensus Committee (NACC) recommendations for infection prevention and management.Neuromodulation. 2017; 20: 31-50
- The incidence of spinal cord injury in implantation of percutaneous and paddle electrodes for spinal cord stimulation.Neuromodulation. 2016; 19: 85-90
- One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic pain.Neuromodulation. 2015; 18 (discussion 48–49): 41-48
- The Second ASRA Practice Advisory on Neurologic Complications Associated With Regional Anesthesia and Pain Medicine: executive summary 2015.Reg Anesth Pain Med. 2015; 40: 401-430
- Diffuse non-aneurysmal SAH in spontaneous intracranial hypotension: sequela of ventral CSF leak?.Cephalalgia. 2016; 36: 589-592
- Spontaneous intracranial hypotension.Continuum. 2015; 21: 1086-1108
- Post-dural puncture headache. II. Prevention, management, and prognosis.Headache. 2010; 50: 1482-1498
- The appropriate use of neurostimulation: new and evolving neurostimulation therapies and applicable treatment for chronic pain and selected disease states.Neuromodulation. 2014; 17: 599-615
- Chronic pain management: American Society of Anesthesiologists Closed Claims Project.Anesthesiology. 2004; 100: 98-105
- Incidence and characteristics of complications from epidural steroid injections.Pain Med. 2011; 12: 726-731
- Is spinal cord stimulation safe? A review of its complications.World Neurosurgery. 2014; 82: 1359-1368
- Complications of spinal cord stimulation: identification, treatment, and prevention.Pain Med. 2008; 9: S93-S101
- Management of cerebral spinal fluid leak complicating spinal cord stimulator implantation.Pain Pract. 2006; 6: 285-288
- Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial.Diabetes Care. 2014; 37: 3016-3024
- Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review.J Neurosurg. 2004; 100: 254-267
- Retrospective review of 707 cases of spinal cord stimulation: indications and complications.Pain Pract. 2011; 11: 148-153
- Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy.New Engl J Med. 2000; 343: 618-624
- The incidence and management of postdural puncture headache in patients undergoing percutaneous lead placement for spinal cord stimulation.Neuromodulation. 2016; 19: 738-743
- The management of accidental dural puncture and postdural puncture headache: a North American survey.J Clin Anesth. 2011; 23: 349-360
- Subdural hematoma following spinal cord stimulator implant.Pain Physician. 2008; 11: 97-101
- ASRA Practice Advisory on Neurologic Complications in Regional Anesthesia and Pain Medicine.Reg Anesth Pain Med. 2008; 33: 404-415
- Epidural hematomas after removal of percutaneous spinal cord stimulator trial leads: two case reports.Reg Anesth Pain Med. 2014; 39: 73-77
- Epidural hematoma and paraplegia after spinal cord stimulator trial lead removal: a case report.PM R. 2014; 1: S361-S362
- Iatrogenic spinal hematoma as a complication of lumbar puncture: what is the risk and best management plan?.Surg Neurol Int. 2016; 7: S581-S589
- Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience.Neurosurgery. 2006; 58 (discussion 481–496): 481-496
- Novel 10-kHz High-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial.Anesthesiology. 2015; 123: 851-860
- Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain.Reg Anesth Pain Med. 2015; 40: 182-212
- Injury and liability associated with implantable devices for chronic pain.Anesthesiology. 2016; 124: 1384-1393
- Complications of spinal cord stimulation.in: Ranson M Pope JE Deer T Reducing Risks and Complications of Interventional Pain Procedures. Saunders, Philadelphia2012: 3-10
- Complications of spinal cord stimulation, suggestions to improve outcome, and financial impact.J Neurosurg Spine. 2006; 5: 191-203
- Epidural abscess due to spinal cord stimulator trial.Pain Pract. 2008; 8: 324-328
- Infection rates of percutaneously implanted leads for SCS after a trial phase: three-year follow up [abstr].Neuromodulation. 2013; 16: e106
- Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center.Pain Physician. 2013; 16: 251-257
- Treatment-limiting complications of percutaneous spinal cord stimulator implants: a review of eight years of experience from an academic center database.Neuromodulation. 2015; 18 (discussion 608–609): 603-608
- Management of thoracic epidural abscess post spinal cord stimulator insertion-a case report [abstr].Neuromodulation. 2013; 16: e70
- Long-term outcome of spinal cord stimulation and hardware complications.Stereo Funct Neurosurg. 2003; 81: 50-56
- Introduction of infection control measures to reduce infection associated with implantable pain therapy devices.Pain Pract. 2007; 7: 279-284
- Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections.Anesthesiology. 2004; 100: 1582-1594
- Dorsal myelopathy secondary to epidural fibrous scar tissue around a spinal cord stimulation electrode.J Neurosurg Spine. 2012; 17: 598-601
- Cervical cord compression due to delayed scarring around epidural electrodes used in spinal cord stimulation.J Neurosurg Spine. 2010; 12: 409-412
- Spinal cord compression from a foreign body reaction to spinal cord stimulation: a previously unreported complication.Spine. 2010; 35: E1516-E1519
- Spinal stimulator peri-electrode masses: case report.J Neurosurg Spine. 2015; 22: 70-74
- Quadriparesis and spinal cord stimulation: case report.Spine. 2007; 32: E565-E568
- Huge epidural hematoma after surgery for spinal cord stimulation.Acta Neurochirurg. 2005; 147: 565-567; discussion 567
- Spinal cord stimulator and epidural haematoma.Br J Anaesth. 2012; 109: 649-650
- A report of paraparesis following spinal cord stimulator trial, implantation and revision.Pain Physician. 2010; 13: 357-363
- Neuromonitoring protocol for spinal cord stimulator cases with case descriptions.Int J Acad Med. 2016; 3
- Awake vs. asleep placement of spinal cord stimulators: a cohort analysis of complications associated with placement.Neuromodulation. 2011; 14 (discussion 134–135): 130-134
- Intraoperative neurophysiologic methods for spinal cord stimulator placement under general anesthesia.Neuromodulation. 2012; 15 (discussion 571–562): 560-571
- Risk factors for hemorrhage during microelectrode-guided deep brain stimulation and the introduction of an improved microelectrode design.Neurosurgery. 2009; 64 (discussion 762–753): 754-762
- Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders.Neurosurgery. 2005; 56 (discussion 722-732): 722-732
- An analysis of the respective risks of hematoma formation in 361 consecutive morphological and functional stereotactic procedures.Neurosurgery. 2002; 50 (discussion 56–47): 48-56
- Hardware-related infections after deep brain stimulation surgery: review of incidence, severity and management in 212 single-center procedures in the first year after implantation.Acta Neurochir. 2011; 153: 2337-2341
- Acute complications of movement disorders surgery: effects of age and comorbidities.Mov Disord. 2013; 28: 1661-1667
- Incidence of symptomatic hemorrhage after stereotactic electrode placement.J Neurosurg. 2007; 107: 998-1003
- Deep brain stimulator hardware-related infections: incidence and management in a large series.Neurosurgery. 2008; 62 (discussion 366–367): 360-366
- Skin complications in deep brain stimulation for Parkinson’s disease: frequency, time course, and risk factors.Acta Neurochir. 2010; 152: 195-200
- Chronic motor cortex stimulation for the treatment of central pain.Acta Neurochir Suppl. 1991; 52: 137-139
- Primary motor cortex stimulation within the central sulcus for treating deafferentation pain.Acta Neurochir Suppl. 2003; 87: 149-152
- Motor cortex stimulation for facial chronic neuropathic pain: a review of the literature.Surg Neurol Int. 2012; 3: S290-S311
- Chronic motor cortex stimulation in the treatment of central and neuropathic pain. Correlations between clinical, electrophysiological and anatomical data.Pain. 1999; 82: 245-251
- Lack of efficacy of motor cortex stimulation for the treatment of neuropathic pain in 14 patients.Neuromodulation. 2014; 17 (discussion 310–301): 303-310
- Motor cortex stimulation for refractory neuropathic pain: four year outcome and predictors of efficacy.Pain. 2005; 118: 43-52
- Invasive brain stimulation for the treatment of neuropathic pain.Nat Rev Neurol. 2011; 7: 699-709
- Recurrent seizures related to motor cortex stimulator programming.Neuromodulation. 2010; 13: 37-43
- Motor cortex stimulation for long-term relief of chronic neuropathic pain: a 10 year experience.Pain. 2006; 121: 43-52
- Efficacy of motor cortex stimulation in the treatment of neuropathic pain: a randomized double-blind trial.J Neurosurg. 2008; 108: 698-706
- Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain.Brain. 2009; 132 (Part 6): 1463-1471
- Motor cortex stimulation for the treatment of neuropathic pain.in: Krames ES Peckham PH Rezai AR Neuromodulation. Elsevier, Amsterdam2009: 515-526
- Treatment of poststroke pain by epidural motor cortex stimulation with a new octopolar lead.Neurosurgery. 2011; 68 (discussion 187): 180-187
- Simultaneous deep brain stimulation/motor cortex stimulation trial for neuropathic pain: fishing with dynamite?.Stereotact Funct Neurosurg. 2015; 93: 219
- Treatment of chronic neuropathic pain by motor cortex stimulation: results of a bicentric controlled crossover trial.Brain Stim. 2008; 1: 89-96
- Ultrasound-guided permanent implantation of peripheral nerve stimulation (PNS) system for neuropathic pain of the extremities: original cases and outcomes.Pain Med. 2009; 10: 1369-1377
- Long-term pain control by direct peripheral-nerve stimulation.J Bone Joint Surg Am. 1982; 64: 1-10
- Direct nerve stimulation for painful peripheral neuropathies.J Bone Joint Surg Br. 1985; 67: 470-472
- The future of peripheral nerve stimulation.Prog Neurol Surg. 2011; 24: 210-217
- An update on peripheral nerve stimulation.J Neurosurg Sci. 2012; 56: 279-285
- Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study.Cephalalgia. 2015; 35: 344-358
- A retrospective analysis of reasons for reoperation following initially successful peripheral nerve stimulation.J Neurosurg. 2007; 106: 388-390
- Chronic post-traumatic neuropathic pain of brachial plexus and upper limb: a new technique of peripheral nerve stimulation.Neurosurg Rev. 2014; 37 (discussion 479–480): 473-479
- Prospective, multicenter, randomized, double-blind, partial crossover study to assess the safety and efficacy of the novel neuromodulation system in the treatment of patients with chronic pain of peripheral nerve origin.Neuromodulation. 2016; 19: 91-100
- Mathematical model of nerve fiber activation during low back peripheral nerve field stimulation: analysis of electrode implant depth.Neuromodulation. 2014; 17 (discussion 225): 218-225
- Muscle activation during peripheral nerve field stimulation occurs due to recruitment of efferent nerve fibers, not direct muscle activation.Neuromodulation. 2016; 19: 587-596
- Nerve fiber activation during peripheral nerve field stimulation: importance of electrode orientation and estimation of area of paresthesia.Neuromodulation. 2016; 19: 311-318
- Peripheral nerve field stimulation (PNFS) in chronic low back pain: a prospective multicenter study.Neuromodulation. 2014; 17: 180-187
- Peripheral nerve field stimulation for the management of localized chronic intractable back pain: results from a randomized controlled study.Neuromodulation. 2013; 16 (discussion 574–565): 565-574
- Peripheral nerve stimulation for the treatment of chronic intractable headaches: long-term efficacy and safety study.Pain Physician. 2015; 18: 505-516
- An international survey to understand infection control practices for spinal cord stimulation.Neuromodulation. 2015; 19: 71-84
- Percutaneous peripheral neuromodulation lead insertion using a novel stimulating Coude needle.Neuromodulation. 2014; 17: 506-509
- Evaluation of magnetic resonance imaging issues for a wirelessly powered lead used for epidural, spinal cord stimulation.Neuromodulation. 2014; 17 (discussion 339): 334-339
- Utilization of spinal cord stimulation in patients with failed back surgery syndrome.Spine. 2014; 39: E719-E727
COMMENTS
Article info
Publication history
Accepted:
November 7,
2016
Received:
October 16,
2016
Footnotes
For more information on author guidelines, an explanation of our peer review process, and conflict of interest informed consent policies, please go to http://www.wiley.com/WileyCDA/Section/id-301854.html
Identification
Copyright
© 2017 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.
